Literature DB >> 16372231

Adipokine expression profile in adipocytes of different mouse models of obesity.

J Boucher1, I Castan-Laurell, D Daviaud, C Guigné, M Buléon, C Carpéné, J S Saulnier-Blache, P Valet.   

Abstract

Adipose tissue produces and secretes multiple adipokines. Most studies on adipokine production/expression have been performed on whole adipose tissue. In addition, data concerning an overall of adipokine expression are scarce and can be heterogeneous depending on the obesity model studied. Our first aim was to compare the expression of adipokines involved in the interplay between obesity and insulin resistance in isolated adipocytes from different mouse models of obesity displaying different levels of weight gain and insulin sensitivity. The second aim was to determine perigonadal/subcutaneous ratio of each adipokine. Only resistin expression was decreased in obese mice without modifications in glucose and insulin blood levels. In addition to decreased levels of resistin, obesity models associated with hyperglycemia and hyperinsulinemia presented an increased expression of leptin and tumor necrosis factor-alpha (TNFalpha). Obese and diabetic mice were the only animals to exhibit high expression of plasminogen activator inhibitor type-1 and interleukin-6. All adipokines except TNFalpha were more heavily expressed in perigonadal than in subcutaneous adipocytes. Interestingly, fat-enriched diet and overweight on their own did not modify the distribution of adipokines between the two fat depots. However, severe obesity modified the distribution of proinflammatory adipokines. In conclusion, the level and number of adipokines with altered expression increased with obesity and hyperinsulinemia in mice. The physiopathological impact of depot-specific differences of adipokine expression in adipocytes remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16372231     DOI: 10.1055/s-2005-921098

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  12 in total

1.  Impaired expression of the inducible cAMP early repressor accounts for sustained adipose CREB activity in obesity.

Authors:  Dimitri Favre; Eric Le Gouill; Denis Fahmi; Chantal Verdumo; Giulia Chinetti-Gbaguidi; Bart Staels; Robert Caiazzo; François Pattou; Kim-Anne Lê; Luc Tappy; Romano Regazzi; Vittorio Giusti; Peter Vollenweider; Gérard Waeber; Amar Abderrahmani
Journal:  Diabetes       Date:  2011-10-12       Impact factor: 9.461

2.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

3.  Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days.

Authors:  Jaime S Rosa; Rebecca L Flores; Stacy R Oliver; Andria M Pontello; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Appl Physiol (1985)       Date:  2009-12-10

4.  Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.

Authors:  Gilberto Paz-Filho; Claudio Mastronardi; Tuncay Delibasi; Ma-Li Wong; Julio Licinio
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-11

5.  Circulating levels of apelin, glucagon-like peptide and visfatin in hypercholesterolemic-hyperhomocysteinemic guinea-pigs: their relation with NO metabolism.

Authors:  Zeynep Kusku-Kiraz; Sema Genc; Seldag Bekpinar; Yesim Unlucerci; Vakur Olgac; Mujdat Uysal; Figen Gurdol
Journal:  Mol Cell Biochem       Date:  2014-11-08       Impact factor: 3.396

6.  Metabolic syndrome and obesity in an insect.

Authors:  Rudolf J Schilder; James H Marden
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

7.  Endoplasmic reticulum stress regulates adipocyte resistin expression.

Authors:  Martina I Lefterova; Shannon E Mullican; Takuya Tomaru; Mohammed Qatanani; Michael Schupp; Mitchell A Lazar
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

8.  International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.

Authors:  Beverley Balkau; John E Deanfield; Jean-Pierre Després; Jean-Pierre Bassand; Keith A A Fox; Sidney C Smith; Philip Barter; Chee-Eng Tan; Luc Van Gaal; Hans-Ulrich Wittchen; Christine Massien; Steven M Haffner
Journal:  Circulation       Date:  2007-10-23       Impact factor: 29.690

9.  Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Authors:  Josep Mercader; Zsuzsa Iffiú-Soltész; Sandy Bour; Christian Carpéné
Journal:  J Obes       Date:  2011-02-08

10.  Reduced Slc2a4/GLUT4 expression in subcutaneous adipose tissue of monosodium glutamate obese mice is recovered after atorvastatin treatment.

Authors:  Ana Cláudia Poletto; Aline David-Silva; Aline Pedro de Melo Yamamoto; Ubiratan Fabres Machado; Daniela Tomie Furuya
Journal:  Diabetol Metab Syndr       Date:  2015-03-14       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.